See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $452B | 7.4x | 17.3x | |
| $357B | 4.2x | 15.0x | |
| $245B | 4.8x | 19.8x | |
| $166B | 2.5x | 11.3x | |
| $82.7B | 1.6x | 7.4x | |
| $72.8B | 3.6x | 14.8x | |
| $67.1B | 3.5x | 12.7x | |
| $61.2B | 8.5x | 36.9x | |
| $54.5B | 3.7x | 14.6x | |
| $51.0B | 9.9x | 42.9x | |
| $48.2B | 3.3x | 22.6x | |
| $42.5B | 4.5x | 18.6x | |
| $40.2B | 2.7x | 12.1x | |
| $34.3B | 1.4x | 7.9x | |
| $31.9B | 2.6x | 17.5x | |
| $22.6B | 1.5x | 8.1x | |
| $22.5B | 2.2x | 6.3x | |
| $22.5B | 3.6x | 16.0x | |
| $21.8B | 1.9x | 10.9x | |
| $17.8B | 1.7x | 10.9x | |
| $14.1B | 8.3x | 40.4x | |
| $12.8B | 2.1x | 14.5x | |
| $11.9B | 2.0x | 10.0x | |
| $10.7B | 7.6x | 42.1x | |
| $10.6B | 6.9x | 27.4x | |
| $10.0B | 6.8x | 36.4x | |
| $8.0B | 1.3x | 7.5x | |
| $7.6B | 1.2x | 14.0x | |
| $7.0B | 1.2x | 6.7x | |
| $6.1B | 9.0x | 28.2x | |
| $6.0B | 2.8x | 15.9x | |
| $5.9B | 3.9x | 19.5x | |
| $5.9B | 5.9x | 22.9x | |
| $5.3B | 1.2x | 7.3x | |
| $4.8B | 1.6x | 10.8x | |
| $4.6B | 1.6x | 6.8x | |
| $4.5B | 9.1x | 35.4x | |
| $4.2B | 9.9x | 30.3x | |
| $4.0B | 1.2x | 6.8x | |
| $4.0B | 3.6x | 10.9x | |
| $3.8B | 1.2x | 7.6x | |
| $3.6B | 3.0x | 18.4x | |
| $3.5B | 1.7x | 10.1x | |
| $3.4B | 2.1x | 11.6x | |
| $3.4B | 3.9x | 9.7x | |
| $3.2B | 1.5x | 10.9x | |
| $2.9B | 2.0x | 9.6x | |
| $2.8B | 0.8x | 5.3x | |
| $2.8B | n/a | n/a | |
| $2.7B | 0.6x | 5.2x | |
| $2.7B | 2.6x | 11.4x | |
| $2.6B | 1.0x | 7.8x | |
| $2.6B | 1.1x | 5.5x | |
| $2.4B | 5.5x | 20.7x | |
| $2.4B | 4.2x | 20.5x | |
| $2.3B | n/a | n/a | |
| $2.2B | 0.5x | 6.4x | |
| $2.0B | n/a | n/a | |
| $2.0B | n/a | n/a | |
| $2.0B | n/a | n/a | |
| $2.0B | n/a | n/a | |
| $1.9B | 2.8x | 13.2x | |
| $1.8B | 1.1x | 9.4x | |
| $1.8B | n/a | n/a | |
| $1.6B | n/a | n/a | |
| $1.6B | 6.2x | 17.4x | |
| $1.5B | 1.2x | 8.1x | |
| $1.4B | 0.7x | 7.6x | |
| $1.4B | n/a | n/a | |
| $1.4B | 1.8x | 7.5x | |
| $1.4B | 0.8x | 6.3x | |
| $1.3B | 0.6x | 5.8x | |
| $1.2B | 2.8x | 12.9x | |
| $1.1B | 1.5x | 10.4x | |
| $1.0B | 7.9x | 29.6x | |
| $1.0B | 4.0x | 57.8x | |
| $935M | 0.8x | 7.7x | |
| $922M | 2.0x | 9.7x | |
| $874M | 1.1x | 5.9x | |
| $725M | n/a | n/a | |
| $655M | n/a | n/a | |
| $603M | 0.9x | 4.1x | |
| $590M | 0.2x | 1.3x | |
| $586M | 1.4x | 8.1x | |
| $575M | 0.8x | 6.5x | |
| $559M | n/a | n/a | |
| $557M | 3.2x | 12.9x | |
| $542M | 0.4x | n/a | |
| $478M | 1.6x | -22.6x | |
| $411M | 2.0x | -44.6x | |
| $405M | n/a | n/a | |
| $368M | 1.3x | 16.7x | |
| $346M | 1.2x | 9.3x | |
| $338M | 0.8x | 9.6x | |
| $307M | n/a | n/a | |
| $299M | n/a | n/a | |
| $241M | 4.6x | 17.7x | |
| $232M | 0.6x | 10.5x | |
| $225M | n/a | n/a | |
| $209M | 0.4x | 12.3x | |
| $200M | 1.4x | 6.1x | |
| $192M | 1.0x | 9.4x | |
| $188M | 2.3x | 13.3x | |
| $178M | 0.9x | 3.9x | |
| $169M | 0.7x | 6.8x | |
| $157M | 0.8x | 5.7x | |
| $150M | n/a | n/a | |
| $139M | 2.2x | 8.2x | |
| $131M | n/a | n/a | |
| $129M | 0.5x | 5.9x | |
| $86.5M | n/a | n/a | |
| $67.4M | 0.3x | 7.0x | |
| $59.9M | 2.3x | 9.7x | |
| $50.7M | 1.1x | n/a | |
| $43.9M | n/a | n/a | |
| $40.2M | n/a | n/a | |
| $39.6M | n/a | n/a | |
| $38.9M | n/a | n/a | |
| $30.8M | n/a | n/a | |
| $28.0M | 2.2x | n/a | |
| $25.9M | 1.4x | -15.3x | |
| $24.2M | n/a | n/a | |
| $18.4M | n/a | n/a | |
| $8.5M | n/a | n/a | |
| $8.2M | n/a | n/a | |
| $7.9M | n/a | n/a | |
| $6.0M | n/a | n/a | |
| $1.4M | n/a | n/a | |
| -$35.7M | -0.1x | -59.6x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty